Terns Pharmaceuticals Income Statement (2020-2025) | TERN

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
8.73M5.96M7.15M9.46M37.42M63.50M70.11M77.89M
Selling, General & Administrative (Quarter)
4.56M4.86M4.71M5.42M5.69M5.42M5.13M6.17M
Other Operating Expenses (Quarter)
8.14M8.66M12.16M-26.76M
Operating Expenses (Quarter)
13.30M10.82M11.87M14.88M13.82M14.08M17.29M16.83M63.50M70.11M77.89M
Operating Income (Quarter)
-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M
EBIT (Quarter)
-13.30M-10.82M-11.87M-13.88M-13.82M-14.08M-17.29M-16.83M-21.47M-17.82M-29.71M-20.97M-22.28M-22.68M-21.88M67.25M-23.82M-24.03M-24.59M-23.19M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.06M0.05M0.06M0.07M0.21M0.50M1.33M
Other Non Operating Income (Quarter)
-0.01M0.04M0.00M0.01M0.00M-0.05M-0.01M-0.00M
Non Operating Income (Quarter)
-0.00M0.04M0.00M0.07M0.07M-0.05M0.48M-0.79M
Net income details
EBT (Quarter)
-13.30M-10.72M-11.81M35.92M-13.75M-13.92M-16.81M-15.50M-21.47M-17.82M-29.71M-20.97M-22.28M-22.68M-21.88M67.25M-23.82M-24.03M-24.59M-23.19M
Tax Provisions (Quarter)
0.04M0.01M0.02M0.35M0.02M0.01M0.01M0.32M0.06M0.07M0.06M0.07M0.10M0.06M0.06M0.04M0.09M0.06M0.05M0.03M
Profit After Tax (Quarter)
-13.34M-10.74M-11.84M-14.25M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.02M-22.37M-22.74M-21.95M-21.80M-23.91M-24.09M-24.64M-23.57M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-13.34M-10.74M-11.84M35.57M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.04M-22.37M-22.74M-21.95M67.21M-23.91M-24.09M-24.64M-23.22M
Consolidated Net Income (Quarter)
-13.34M-10.74M-11.84M35.57M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.04M-22.37M-22.74M-21.95M67.21M-23.91M-24.09M-24.64M-23.22M
Income towards Parent Company (Quarter)
-13.34M-10.74M-11.84M35.57M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.04M-22.37M-22.74M-21.95M67.21M-23.91M-24.09M-24.64M-23.22M
Net Income towards Common Stockholders (Quarter)
-13.34M-10.74M-11.84M35.57M-13.77M-13.93M-16.82M-15.82M-21.53M-17.90M-29.77M-21.04M-22.37M-22.74M-21.95M67.21M-23.91M-24.09M-24.64M-23.22M
Additional items
EPS (Basic) (Quarter)
-0.43-0.43-0.47-0.57-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29-0.30-0.31-0.28-0.23-0.26-0.26-0.27-0.24
EPS (Weighted Average and Diluted) (Quarter)
-0.541.57-0.55-0.55-0.44-0.17-0.31-0.25-0.42-0.29-0.30-0.31-0.28-0.23-0.26-0.26-0.27-0.24
Shares Outstanding (Weighted Average) (Quarter)
15.16M20.16M25.15M22.71M25.27M25.30M29.74M36.03M69.78M71.36M71.53M71.26M74.40M74.43M75.57M79.51M91.47M91.58M91.58M93.17M
Shares Outstanding (Diluted Average) (Quarter)
21.84M22.71M25.27M25.29M38.51M36.03M69.78M71.36M70.90M71.26M74.40M74.46M77.82M79.51M91.47M91.52M91.70M93.17M
EBITDA (Quarter)
-13.45M-10.68M-11.83M-13.88M-14.33M-14.28M-16.93M-16.83M-21.12M-18.25M-29.83M-20.97M-22.68M-22.86M-21.34M67.25M-23.58M-24.17M-24.50M-23.19M
Tax Rate (Quarter)
-0.29%-0.13%-0.17%0.96%-0.15%-0.04%-0.08%-2.05%-0.28%-0.40%-0.20%-0.32%-0.44%-0.27%-0.28%0.06%-0.37%-0.27%-0.19%-0.14%